Stock Code: 301509 Stock Abbreviation: Jinkai Life Science
Jinkai (Liaoning) Life Science Co., Ltd.
2026 Restricted Stock and Stock Appreciation Rights Incentive Plan (Draft)
July 2026
Statement
The Board of Directors and all directors of the Company guarantee that the contents of this announcement do not contain any false records, misleading statements, or major omissions, and assume legal responsibility for the authenticity, accuracy, and completeness of its contents.
All incentive recipients of the Company undertake that if the Company fails to meet the conditions for the grant or vesting/exercise of rights due to false records, misleading statements, or major omissions in information disclosure documents, the incentive recipients shall return all benefits obtained from this incentive plan to the Company after the relevant information disclosure documents are confirmed to contain false records, misleading statements, or major omissions.
Special Notice
-
This incentive plan is formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, the Rules Governing the Listing of Stocks on the ChiNext Market of the Shenzhen Stock Exchange, the Guidelines for Self-Regulation of Listed Companies on the ChiNext Market No. 1 — Business Handling, and other relevant laws, regulations, and normative documents, as well as the Articles of Association of Jinkai (Liaoning) Life Science Co., Ltd.
-
This incentive plan includes two parts: a restricted stock incentive plan (Type II restricted stock) and a stock appreciation rights incentive plan, which are independent of each other. The source of the restricted stock is the Company's定向 issuance of A-share common stock to the incentive recipients. Incentive recipients who are granted restricted stock will, upon meeting the corresponding vesting conditions, obtain the Company's A-share common stock issued to them at the grant price in batches, which will be registered with the Shenzhen Branch of China Securities Depository and Clearing Corporation. Before vesting, the restricted stock granted to the incentive recipients does not carry shareholder rights and may not be transferred, used for guarantees, or used to repay debts. Stock appreciation rights do not involve actual shares of the Company; they use the Company's A-share common stock as the virtual stock underlying asset, where one unit of stock appreciation right virtually corresponds to one A-share common stock. Provided that performance assessment standards are met, the Company will pay the incentive amount in cash.
-
This incentive plan intends to grant 2.07 million restricted shares to incentive recipients, accounting for approximately 1.72% of the Company's total share capital of 120.446669 million shares at the time of the announcement of this draft. The grant of restricted stock under this plan is a one-time grant with no reserved interests. At the same time, it is intended to grant 320,000 stock appreciation rights to incentive recipients, accounting for approximately 0.27% of the Company's total share capital of 120.446669 million shares at the time of the announcement of this draft. Of this, 270,000 units are granted initially, accounting for approximately 0.22% of the Company's total share capital, representing 84.38% of the total equity granted this time. The remaining 50,000 units are reserved, accounting for 0.04% of the total share capital and 15.63% of the total equity granted this time.
The total number of underlying shares involved in all of the Company's equity incentive plans within the validity period does not exceed 20.00% of the Company's total share capital at the time of the announcement of this draft. The cumulative number of company shares granted to any single incentive recipient through all equity incentive plans within the validity period does not exceed 1.00% of the Company's total share capital at the time of the announcement of this draft.